An investigation into risk factors associated with rapid clinical progression, from MCI to dementia, highlights the significance of cerebrospinal fluid (CSF) total tau and phosphorylated tau, but not βA1–42 levels, as pertinent to disease [36]. The gene discussed is MAPT; the disease is dementia.